These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6442873)

  • 1. Antibiotic resistance resulting from decreased drug accumulation.
    Chopra I
    Br Med Bull; 1984 Jan; 40(1):11-7. PubMed ID: 6442873
    [No Abstract]   [Full Text] [Related]  

  • 2. Intrinsic antibiotic resistance of Pseudomonas aeruginosa.
    Hancock RE
    J Antimicrob Chemother; 1986 Dec; 18(6):653-6. PubMed ID: 3102446
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiantibiotic resistance caused by active drug extrusion in Pseudomonas aeruginosa and other gram-negative bacteria.
    Nakae T
    Microbiologia; 1997 Sep; 13(3):273-84. PubMed ID: 9353746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial resistance to antibiotics as a function of outer membrane permeability.
    Nikaido H
    J Antimicrob Chemother; 1988 Jul; 22 Suppl A():17-22. PubMed ID: 3062001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial efflux systems.
    Marshall NJ; Piddock LJ
    Microbiologia; 1997 Sep; 13(3):285-300. PubMed ID: 9353747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial peptides and the outer membranes of gram-negative bacilli.
    Hancock RE
    J Med Microbiol; 1997 Jan; 46(1):1-3. PubMed ID: 9003734
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic Efficacy of Aedes aegypti Antimicrobial Peptide Cecropin A2 and Tetracycline against Pseudomonas aeruginosa.
    Zheng Z; Tharmalingam N; Liu Q; Jayamani E; Kim W; Fuchs BB; Zhang R; Vilcinskas A; Mylonakis E
    Antimicrob Agents Chemother; 2017 Jul; 61(7):. PubMed ID: 28483966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The problems in the outer membrane permeability and the antibiotic resistance of Pseudomonas aeruginosa.
    Nakae T
    Kitasato Arch Exp Med; 1991 Sep; 64(2-3):115-21. PubMed ID: 1667326
    [No Abstract]   [Full Text] [Related]  

  • 9. [Plasmids and genetic determinants of antibiotic resistance of gram-negative bacteria].
    Erova TE; Anisimova LA; Smolianskaia AZ; Boronin AM
    Antibiot Khimioter; 1989 May; 34(5):365-70. PubMed ID: 2500901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of mex-gene products in antibiotic extrusion in Pseudomonas aeruginosa.
    Yoneyama H; Ocaktan A; Tsuda M; Nakae T
    Biochem Biophys Res Commun; 1997 Apr; 233(3):611-8. PubMed ID: 9168899
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Occurrence of antipseudomonal beta-lactams and aminoglycosides resistance in Pseudomonas aeruginosa during therapy.
    Pagani L; Scarabelli M; Cereda PM; Debiaggi M
    Microbiologica; 1987 Jan; 10(1):103-10. PubMed ID: 3106759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of porins in the antibiotic susceptibility of Pseudomonas aeruginosa: construction of mutants with deletions in the multiple porin genes.
    Yoneyama H; Yamano Y; Nakae T
    Biochem Biophys Res Commun; 1995 Aug; 213(1):88-95. PubMed ID: 7639767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Tetracycline resistance controlled by plasmids of Pseudomonas aeruginosa with a wide spectrum of bacterial hosts].
    Kozlova EV; Boronin AM
    Antibiot Med Biotekhnol; 1985 Feb; 30(2):83-6. PubMed ID: 3923917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Mechanism of susceptibility and resistance of Pseudomonas aeruginosa to aminoglycosides].
    Iyobe S
    Nihon Rinsho; 1991 Oct; 49(10):2249-53. PubMed ID: 1749079
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of antibiotics on extracellular protein level in Pseudomonas aeruginosa.
    Takahashi E; Lee JM; Mon H; Chieda Y; Yasunaga-Aoki C; Kusakabe T; Iiyama K
    Plasmid; 2016; 84-85():44-50. PubMed ID: 26997534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic resistance mechanisms in Pseudomonas aeruginosa.
    Stratton CW; Tausk F
    J Antimicrob Chemother; 1987 Apr; 19(4):413-6. PubMed ID: 3034848
    [No Abstract]   [Full Text] [Related]  

  • 17. Resistance to beta-lactams in gram-negative bacteria: relative contributions of beta-lactamase and permeability limitations.
    Nayler JH
    J Antimicrob Chemother; 1987 Jun; 19(6):713-32. PubMed ID: 3301784
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta-lactam resistant Pseudomonas aeruginosa strains emerging during therapy: synergistic resistance mechanisms.
    Pagani L; Debiaggi M; Tenni R; Cereda PM; Landini P; Romero E
    Microbiologica; 1988 Jan; 11(1):47-53. PubMed ID: 2832709
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MexAB-OprM- and MexXY-overproducing mutants are very prevalent among clinical strains of Pseudomonas aeruginosa with reduced susceptibility to ticarcillin.
    Hocquet D; Roussel-Delvallez M; Cavallo JD; Plésiat P
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1582-3. PubMed ID: 17220417
    [No Abstract]   [Full Text] [Related]  

  • 20. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance.
    Mah TF; Pitts B; Pellock B; Walker GC; Stewart PS; O'Toole GA
    Nature; 2003 Nov; 426(6964):306-10. PubMed ID: 14628055
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.